Skip to main content
SpringerLink
Log in

Immune Reactions in Liver Diseases

  • Chapter
Clinical Hepatology

  • 143 Accesses

Abstract

Chronic hepatitis is a heterogeneous syndrome with different underlying etiologies. Viruses (hepatitis B virus, non-A, non-B viruses), drugs and even alcohol are regarded as etiological agents. A further subgroup is autoimmune-type chronic hepatitis in which an immunogenetic predisposition is of major importance. Primary biliary cirrhosis has to be separated from these subgroups of chronic hepatitis.

This work was supported by the Deutsche Forschungsgemeinschaft, grant Me 244/13

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alberti A, Realdi G, Bortolotti F, Rigoli AM (1977) T-lymphocyte cytotoxicity to HBsAg-coated target cells in hepatitis B virus infection. GUT 18: 1004–1009

    Article  PubMed  CAS  Google Scholar 

  2. Alexander JJ, Bey EM, Geddes EW, Lecatsas G (1976) Establishment of a continuously growing cell line from primary carcinoma of the liver. S Afr Med J 50: 2124

    PubMed  CAS  Google Scholar 

  3. Bach MA, Bach JF (1981) The use of monoclonal anti-T cell antibodies to study T cell imbalances in human diseases. Clin Exp Immunol 45: 449–456

    PubMed  CAS  Google Scholar 

  4. Behrens UJ, Paronetto F (1979) Studies on ‘liver-specific antigens.’ I. Evaluation of the liver specificity of ‘LSP’ and ‘LP-2. ’ Gastroenterology 77: 1045–1052

    PubMed  CAS  Google Scholar 

  5. Behrens UJ, Vernace S, Paronetto F (1979) Studies on ‘liver-specific’ antigens. II. Detection of serum antibodies to liver and kidney cell membrane antigens in patients with chronic liver disease. Gastroenterology 77: 1053

    PubMed  CAS  Google Scholar 

  6. Berg PA, Doniach D, Roitt IM (1967) Mitochondrial antibodies in primary biliary cirrhosis. I. Localization of the antigen to mitochondrial membranes. J Exp Med 126: 277–293

    Article  PubMed  CAS  Google Scholar 

  7. Berg PA, Binder T, Lindner H, Bannaski H, Maas D, Henning H, Brügel H (1975) Heterogenität mitochondrialer Autoantikörper. Dtsch Med Wochenschr 100: 1123–1127

    Article  PubMed  CAS  Google Scholar 

  8. Berg PA, Wiedmann KH, Sayers T, Klöppel G (1980) Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies. Lancet 11: 1329–1332

    Article  Google Scholar 

  9. Berg PA, Baum H (1980) Serology of primary biliary cirrhosis. Springer Sem Immunopathol 3: 355–373

    Article  CAS  Google Scholar 

  10. Chisari FV (1980) Liver-specific protein in perspective. Gastroenterology 78: 168–170

    PubMed  CAS  Google Scholar 

  11. Chisari FV, Castle KL, Xavier C, Anderson DS (1981) Functional properties of lymphocyte subpopulations in hepatitis B virus infection. I. Suppressor cell control of T lymphocyte responsiveness. J Immunol 126: 38–44

    PubMed  CAS  Google Scholar 

  12. Chisari FV, Bieber MS, Josepho A, Xavier, Anderson DS (1981) Functional properties of lymphocyte subpopulations in hepatitis B virus infection. II. Cytotoxic effector cell killing of targets that naturally express hepatitis B surface antigen and liver-specific lipoprotein. J Immunol 126: 45–49

    PubMed  CAS  Google Scholar 

  13. Cochrane AMG, Moussouros A, Thomson AD et al. (1976) Antibody-dependent cell-mediated ( K cell) cytotoxicity against isolated hepatocytes in chronic active hepatitis. Lancet 1: 441–444

    Article  PubMed  CAS  Google Scholar 

  14. Dienstag JL, Bhan AK (1980) Enhanced in vitro cell-mediated cytotoxicity in chronic hepatitis B virus infection: absence of specificity for virus-expressed antigen on target cell membranes. J Immunol 125: 2269–2276

    PubMed  CAS  Google Scholar 

  15. Doniach D (1979) Diagnostische Autoantikörperbestimmungen bei Lebererkrankungen. In: Kühn HA, Wernze H (Hrsg) Klinische Hepatologie. Thieme, Stuttgart, S 3.50–3. 64

    Google Scholar 

  16. Eddleston ALWF, Williams R (1974) Inadequate antibody response to HBsAg or suppressor T-cell defect in development of active chronic hepatitis. Lancet II: 1543–1545

    Google Scholar 

  17. El Sheikh N, Osman CG, Cullens H, Eddleston ALWF, Williams R (1978) T-lymphocyte-mediated cytotoxicity in HBsAg-positive liver disease. Clin Exp Immunol 31: 158–165

    PubMed  Google Scholar 

  18. Facchini A, Stefanini GF, Bernardi M, Miglio F, Gasbarrini G, Labo G (1978) Lymphocytotoxicity test against rabbit hepatocytes in chronic liver diseases. GUT 19: 189–193

    Article  PubMed  CAS  Google Scholar 

  19. Gerber MA, Lebwohl N, Thung SN, Bodenheimer H, Schaffner F (1979) Antibodies to liver-specific membrane protein in liver and kidney disease ( Abstr ). Gastroenterology 76: 1281

    Google Scholar 

  20. Gerber MA, Garfinkel E, Hirschmann SZ, Thung SN, Panagiotatos T (1981) Immune and enzyme histochemical studies of a human hepatocellular carcinoma cell line producing hepatitis B surface antigen. J Immunol 126: 1085–1090

    PubMed  CAS  Google Scholar 

  21. Geubel AP, Keller RH, Summerskill WHJ, Dickson ER, Tomasi TB, Shorter RG (1976) Lymphocyte cytotoxicity and inhibition studies with autologous liver cells: observations in chronic active liver disease and the primary biliary cirrhosis syndrome. Gastroenterology 71: 450–456

    PubMed  CAS  Google Scholar 

  22. Hamblin TJ (1981) Significance of antimitochondrial antibodies. Lancet 11: 1411–1412

    Article  Google Scholar 

  23. Herberman RB, Djeu JY, Kay HD, Ortaldo JR, Riccardi C, Bonnard GD, Holden HT, Fagnani R, Santoni A, Puccetti P (1979) Natural killer cells: characteristics and regulation of activity. Immunol Rev 44: 43

    Article  PubMed  CAS  Google Scholar 

  24. Hodgson HJF, Wands DR, Isselbacher KJ (1978) Alteration in suppressor cell activity in chronic active hepatitis. Proc Nat Acad Sci USA 75: 1549–1553

    Article  PubMed  CAS  Google Scholar 

  25. Hopf U, Meyer zum Büschenfelde KH, Arnold W (1975) Detection of a cytophilic autoantibody in chronic active hepatitis. Lancet 1: 690–1

    Article  PubMed  CAS  Google Scholar 

  26. Hopf U, Meyer zum Büschenfelde KH, Arnold W (1976) Detection of a liver membrane autoantibody in HBsAg-negative chronic active hepatitis. N Engl J Med 294: 578–582

    Article  PubMed  CAS  Google Scholar 

  27. Hütteroth TH, Meyer zum Büschenfelde KH (1978) Clinical relevance of the liver-specific lipoprotein ( LSP ). Acta Hepato-Gastroenterol 25: 243–253

    Google Scholar 

  28. Hütteroth TH, Meyer zum Büschenfelde KH (1978) Antigenic relationship between Chang liver cells and human hepatocytes. Klin Wochenschr 56: 525–527

    Article  PubMed  Google Scholar 

  29. Hütteroth TH, Meyer zum Büschenfelde KH (1978) IgG binding to the plasma membrane of Chang liver cells in chronic active hepatitis. J Clin Lab Immunol 1: 91–94

    Google Scholar 

  30. Hütteroth TH, Poralla T, Meyer zum Büschenfelde KH (1981) Spontaneous cell-mediated (SCMC) and antibody-dependent cellular cytotoxicity ( ADCC) in patients with acute and chronic active hepatitis. Klin Wochenschr 59: 699–706

    Article  PubMed  Google Scholar 

  31. Hütteroth TH, Poralla T, Meyer zum Büschenfelde KH (1982) Cellular cytotoxicity against the human hepatoma cell line PLC/PRF/5 in patients with hepatitis B virus induced chronic active hepatitis (CAH) and non-A, non-B (NANB) CAH 2: 285–291

    Google Scholar 

  32. Jensen DM, McFarlane IG, Portmann BS, Eddieston DM, Williams R (1978) Detection of antibodies directed against liver-specific lipoprotein in patients with acute and chronic active hepatitis. N Engl J Med 299: 1–7

    Article  PubMed  CAS  Google Scholar 

  33. Kakumu S, Hara T, Goji H, Sakamoto N (1978) Lymphocyte cytotoxicity against Chang liver cells in chronic active hepatitis. Cell Immunol 36: 46

    Article  PubMed  CAS  Google Scholar 

  34. Kakamu S, Arakawa Y, Goji H, Kashio T, Yata K (1979) Occurence and significance of antibody to liverspecific lipoprotein by double-antibody immunoprecipitation method in sera of patients with acute and chronic liver diseases. Gastroenterology 76: 665–672

    Google Scholar 

  35. Kawanishi H, MacDermott RP (1979) K-cell-mediated antibody dependent cellular cytotoxicity in chronic active liver diseases. Gastroenterology 76: 151–158

    PubMed  CAS  Google Scholar 

  36. Klatskin G, Kantor FS (1972) Mitochondrial antibody in primary biliary cirrhosis and other diseases. Ann Intern Med 77: 533–541

    PubMed  CAS  Google Scholar 

  37. Labro MT, Andrieu MC, Weber M, Homberg JC (1978) A new pattern of non-organ- and non-species-specific anti-organelle antibody detected by immunofluorescence: the mitochondrial antibody number 5. Clin Exp Immunol 31: 357–366

    PubMed  CAS  Google Scholar 

  38. Lebwohl N, Gerber MA (1981) Characterization and demonstration of human liver-specific protein ( LSP) and apo-LSP. Clin Exp Immunol 46: 435–442

    Google Scholar 

  39. Maas D, Schubothe H (1973) Ein Lupus-erythematodes-ähnliches Syndrom mit antimitochondrialen Antikörpern. Dtsch Med Wochenschr 98: 131–139

    Article  PubMed  CAS  Google Scholar 

  40. Mackay IR, Taft GD (1980) HLA associations with autoimmune-type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 79: 95

    PubMed  CAS  Google Scholar 

  41. Mac Sween RNM, Anthony RS, Farguharson M (1981) Antibodies to alcohol-altered hepatocytes in patients with alcoholic liver disease ( Letter ). Lancet 11: 803–804

    Article  Google Scholar 

  42. Manns M, Meyer zum Büschenfelde KH, Hütteroth TH, Hopf U (1980) The liver specific protein: evidence for species-specific and non-species-specific determinants. J Clin Lab Immunol 3: 9–13

    PubMed  CAS  Google Scholar 

  43. Manns M, Meyer zum Büschenfelde KH, Hütteroth TH, Hess G (1980) Detection and characterization of liver membrane autoantibodies in chronic active hepatitis by a solid phase radioimmunoassay. Clin Exp Immunol 42: 263–272

    PubMed  CAS  Google Scholar 

  44. Manns M, Meyer zum Büschenfelde KH, Hess G (1980) Autoantibodies against liver-specific membrane lipoprotein in acute and chronic liver diseases: studies on organ-, species-, and disease-specificity. GUT 21: 955–961

    Article  PubMed  CAS  Google Scholar 

  45. Manns M, Arnold W, Meyer zum Büschenfelde KH, Nagai S, Hoffmann H (1981) Studies on anti LSP autoantibodies in acute and chronic non-B hepatitis — Evidence for the lack of anti LSP in non-A, non-B ( NANB) viral hepatitis. Klin Wochenschr 59: 685–689

    Article  PubMed  CAS  Google Scholar 

  46. Manns M, Meyer zum Büschenfelde KH (1982) A mitochondrial antigen-antibody system in cholestatic liver disease detected by radioimmunoassay. Hepatology 2: 1–7

    Article  PubMed  CAS  Google Scholar 

  47. Manns M, Meyer zum Büschenfelde KH (1981) Fractionation of the liver antigen fraction ‘LSP’ and characterization of its antigenic determinants by autoantibodies and a heterologous anti ‘LSP’ serum. GUT 23: 14–20

    Article  Google Scholar 

  48. McFarlane IG, Wojcicka BM, Zucker GM, Eddieston ALWF, Williams R (1977) Purification and characterization of human liver-specific membrane lipoprotein ( LSP ). Clin Exp Immunol 27: 381–390

    PubMed  CAS  Google Scholar 

  49. Meliconi R, Baraldini M, Stefanini GF, Facchini A, Miglio F, Bortolotti F, Alberti A, Realdi G, Amoroso P (1981) Antibodies against human liver-specific protein (LSP) in acute and chronic viral hepatitis types A, B and non-A, non-B. Clin Exp Immunol 46: 382–390

    PubMed  CAS  Google Scholar 

  50. Meyer zum Büschenfelde KH, Miescher PA (1972) Liver specific antigens: purification and characterization of human liver-specific membrane lipoprotein ( LSP ). Clin Exp Immunol 10: 89–102

    PubMed  Google Scholar 

  51. Meyer zum Büschenfelde KH, Manns M, Hütteroth TH, Hopf U, Arnold W (1979) LM-Ag and LSP — two different target antigens involved in the immunopathogenesis of chronic active hepatitis? Clin Exp Immunol 37: 205–212

    PubMed  Google Scholar 

  52. Meyer zum Büschenfelde KH, Hütteroth TH, Arnold W, Hopf U (1979) Immunologic liver injury: the role of hepatitis B viral antigens and liver membrane antigens as targets. In: Popper H, Schaffner F (eds) Progress in liver diseases, vol VI. Grune & Stratton, New York, pp 407–424

    Google Scholar 

  53. Meyer zum Büschenfelde KH, Hütteroth TH, Manns M, Möller B (1980) The role of liver membrane antigens as targets in autoimmune type liver diseases. Springer Sem Immunopathol 3: 297–315

    Article  Google Scholar 

  54. Mieli Vergani G, Vergani D, Jenkins PJ, Portmann B, Mowat AP, Eddieston ALWF, Williams R (1979) Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg-negative chronic active hepatitis. Clin Exp Immunol 38: 16–21

    Google Scholar 

  55. Miyachi K, Gupta RC, Dickson ER, Tan EM (1980) Precipitating antibodies to mitochondrial antigens in patients with primary biliary cirrhosis. Clin Exp Immunol 39: 599–606

    PubMed  CAS  Google Scholar 

  56. Nouri K, Hegarty JE, Eddieston ALWF, Williams R (1981) A suppressor cell defect in autoimmune chronic active hepatitis is reversed by prednisolone (Abstr). 16th Meeting EASL, Lisbon 1981

    Google Scholar 

  57. Perperas A, Tsantoulas D, Portmann B, Eddleston ALWF, Williams R (1981) Autoimmunity to a liver membrane lipoprotein and liver damage in alcoholic liver disease. GUT 22: 149–152

    Article  PubMed  CAS  Google Scholar 

  58. Rizetto M, Bianchi B, Doniach D (1974) Characterization of the microsomal antigen related to a subclass of active chronic hepatitis. Immunology 26: 589

    Google Scholar 

  59. Routhier G, Epstein O, Janossy G, Thomas HC, Sherlock S (1981) Effects of cylosporin A an suppressor and inducer T lymphocytes in primary biliary cirrhosis. Lancet II: 1223–1226

    Google Scholar 

  60. Sayers TJ, Binder T, Berg PA (1979) Heterogeneity of anti-mitochondrial antibodies: characterization and separation of the antigen associated with the pseudolupus erythematosus syndrome. Clin Exp Immunol 37: 68–75

    PubMed  CAS  Google Scholar 

  61. Tage-Jensen U, Arnold W, Dietrichson O, Hardt F, Hopf U, Meyer zum Büschenfelde KH, Nielsen JO (1977) Liver-cell-membrane autoantibody specific for inflammatory liver disease. Br Med J 1: 206–208

    Article  PubMed  CAS  Google Scholar 

  62. Thomas HC, Holden R, Verrier-Jones J, Peacock DB (1976) Immune response to X 174 in man. Primary and secondary antibody production in primary biliary cirrhosis. GUT 17: 844

    Article  PubMed  CAS  Google Scholar 

  63. Thomson AD, Cochrane MAG, McFarlane IG et al. (1974) Lymphocyte cytotoxicity to isolated hepatocytes in chronic active hepatitis. Nature 252: 721–722

    Article  PubMed  CAS  Google Scholar 

  64. Tsantoulas D, Perperas A, Portmann B, Eddleston ALWF, Williams R (1980) Antibodies to a human liver membrane lipoprotein ( LSP) in primary biliary cirrhosis. GUT 21: 557–560

    Article  PubMed  CAS  Google Scholar 

  65. Vergani D, Tsantoulas D, Eddleston ALWF, Davis M, Williams R (1978) Sensitisation to halothane-altered liver components in severe hepatic necrosis after halothane anesthesia. Lancet 11: 801–803

    Article  Google Scholar 

  66. Vergani D, Mieli-Vergani G, Alberti A, Neuberger J, Eddleston ALWF, Davis M, Williams R (1980) Antibodies to the surface of halothane-altered rabbit hepatocytes in patients with severe halothane-associated hepatitis. N Engl J Med 303: 66–71

    Article  PubMed  CAS  Google Scholar 

  67. Vergani GM, Eddleston ALWF (1981) Autoimmunity to liver membrane antigens in acute and chronic hepatitis. In: Holborow DJ (ed) Clinics in immunology and allergy. Saunders, London, pp 181–198

    Google Scholar 

  68. Vierling JM, Nelson DL, Strober W, Bundy BM, Jones EA (1977) In vitro cell-mediated cytotoxicity in primary biliary cirrhosis and chronic hepatitis. J Clin Invest 60: 1116–1128

    Article  PubMed  CAS  Google Scholar 

  69. Vogten AJM, Hadzic N, Shorter RG et al. (1978) Cell-mediated cytotoxicity in chronic active liver disease: a new test system. Gastroenterology 74: 883–889

    PubMed  CAS  Google Scholar 

  70. Walker JG, Doniach D, Roitt IM, Sherlock S (1965) Serological tests in diagnosis of primary biliary cirrhosis. Lancet 1: 827–831

    Article  PubMed  CAS  Google Scholar 

  71. Wands JR, Isselbacher KJ (1975) Lymphocyte cytotoxicity to autologous liver cells in chronic active hepatitis. Proc Natl Acad Sci USA 72: 1301–1303

    Article  PubMed  CAS  Google Scholar 

  72. Wands JR, Perrotto JL, Alpert E, Isselbacher KJ (1975) Cell-mediated immunity in acute and chronic hepatitis. J Clin Invest 55: 921–929

    Article  PubMed  CAS  Google Scholar 

  73. Wilson JD, Booth RJ, Bullock JY, Campbell DG (1980) Anti-mitochondrial antibodies associated with labetalol ( Letter ). Lancet 11: 312–313

    Article  Google Scholar 

  74. Zinkernagel RM, Doherty PC (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphs major transplantation antigens determining T cell restriction-specificity function and responsiveness. Adv Immunol 27: 51

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. I. Medical Clinic und Policlinic, Johannes Gutenberg-Universität Mainz, Langenbeckstr. 1, 6500, Mainz 1, Germany

    M. Manns

Authors
  1. K.-H. Meyer zum Büschenfelde
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. H. Hütteroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Manns
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Clinical Research, Heimhuder Straße 46, D-2000, Hamburg 13, Germany

    Géza Csomós M.D.

  2. School of Medicine, University of Vienna, Austria

    Heribert Thaler M.D. (Assoc. Professor, Head of the 4th Medical Department) (Assoc. Professor, Head of the 4th Medical Department)

  3. Wilhelminenspital of the City of Vienna, 16, Montlearstraße 37, A-1171, Vienna, Austria

    Heribert Thaler M.D. (Assoc. Professor, Head of the 4th Medical Department) (Assoc. Professor, Head of the 4th Medical Department)

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Meyer zum Büschenfelde, KH., Hütteroth, T.H., Manns, M. (1983). Immune Reactions in Liver Diseases. In: Csomós, G., Thaler, H. (eds) Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-68748-8_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-68748-8_14

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-68750-1

  • Online ISBN: 978-3-642-68748-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation